GlassScriptPhysician profile
Ailish Garrett
NPI 1679827570
$8,215.06
in general payments reported to CMS, 2019-2025
58 companies · $1,718 in 2025
The $1,718 reported for 2025 was more than what 93% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,469 · 2022: $2,958 · 2023: $535 · 2024: $535 · 2025: $1,718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,589 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,588.53 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $616.37 | 2021-2025 | Carvykti, Rybrevant, Darzalex |
| Amgen INC. | $604.47 | 2021-2023 | Kyprolis |
| Seagen INC. | $521.80 | 2021-2023 | Adcetris, Tukysa |
| Genzyme Corporation | $428.88 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $419.23 | 2021-2025 | Tagrisso |
| Celgene Corporation | $315.85 | 2021-2025 | Reblozyl |
| Daiichi Sankyo INC. | $314.45 | 2021-2025 | Enhertu, Datroway |
| Merck Sharp & Dohme LLC | $294.19 | 2021-2025 | Keytruda, Lynparza |
| Eisai INC. | $289.97 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $282.71 | 2021-2025 | Libtayo |
| Takeda Pharmaceuticals U.S.A., INC. | $259.18 | 2022-2025 | Entyvio, Ninlaro, Alunbrig |
| Incyte Corporation | $250.32 | 2021-2025 | Monjuvi, Zynyz, Jakafi |
| Glaxosmithkline, LLC. | $249.66 | 2021-2025 | Ojjaara, Jemperli |
| Genentech USA, INC. | $204.23 | 2021-2025 | Polivy |
| E.R. Squibb & Sons, L.L.C. | $192.95 | 2021-2025 | Opdivo |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ailish Garrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.